Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EpiFinder is a digital health company that provides an artificial intelligence-powered clinical decision support platform for the diagnosis of epilepsy and other neurological disorders. The company's technology uses proprietary algorithms to analyze patient-reported symptoms and clinical data, helping physicians identify specific seizure types and epilepsy syndromes at the point of care. By streamlining the diagnostic process, EpiFinder aims to reduce the high rate of misdiagnosis and decrease the time it takes for patients to receive specialized treatment. The platform is designed to integrate with electronic health record systems, facilitating better communication between primary care providers and neurologists. Ultimately, EpiFinder seeks to improve patient outcomes and reduce the economic burden of chronic neurological conditions through earlier and more accurate intervention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EpiFinder.